Results 171 to 180 of about 25,691 (210)

Topotecan

Reactions Weekly, 2022
openaire   +1 more source

Topotecan

Reactions Weekly
  +4 more sources

Topotecan

Reactions Weekly, 2013
openaire   +1 more source

Development of a highly stable and targetable nanoliposomal formulation of topotecan

Journal of Controlled Release, 2010
Dmitri B Kirpotin
exaly  

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet Oncology, The, 2018
Radoslav Chekerov, Sven Mahner, Ahmed El-Balat   +2 more
exaly  

Copper–topotecan complexation mediates drug accumulation into liposomes

Journal of Controlled Release, 2006
Amandeep S Taggar, Marcel B Bally
exaly  

Topotecan

Reactions Weekly, 2018
openaire   +1 more source

Topotecan

Reactions Weekly, 2021
openaire   +1 more source

Topotecan

Reactions Weekly, 2011
openaire   +2 more sources

Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer

Journal of Clinical Oncology, 2007
Jean-Louis Pujol, andrea ardizzoni
exaly